Is Morning Exposure Therapy More Successful? Pilot Data on Exposure Process Indicators and Diurnal Cortisol in Obsessive–Compulsive Disorder or Agoraphobia
Aug 2026· Journal of Clinical Medicine· Vol 15, pp. 6735· 0 citations· 39 references
Medicine
Abstract
Background/Objectives: Glucocorticoids have been shown to improve fear extinction learning in preclinical and human studies. We hypothesized an impact of the circadian rhythm of cortisol on exposure therapy in patients with anxiety spectrum disorders. Methods: Sixteen patients suffering from obsessive–compulsive disorder and eight with agoraphobia participated in a pilot randomized prospective cohort study. During two therapist-guided sessions of exposure therapy with response prevention, both starting either at 08:00 (morning group) or at 16:00 (late afternoon group), subjective units of distress (SUD) and salivary cortisol levels were assessed repeatedly. Results: While expected significant diurnal differences in salivary cortisol emerged between daytime groups, after controlling for chronotype, no significant differences were detected in our exposure process indicators of within-session and between-session habituation and distress-related expectancy violation towards maximal SUD and SUD at end. Nearly one-hundred subjects in each group would be needed to gain statistically significant daytime differences for these indicators as per case number estimation. Conclusions: Our preliminary results from this transdiagnostic sample do not provide support for scheduling exposure sessions in the morning. Further research should consider cortisol administration before exposure sessions to test whether different doses of exogenous glucocorticoids can augment exposure therapy outcomes.
BACKGROUND
Although exposure therapy is considered the gold standard treatment for anxiety disorders, many patients do not respond sufficiently to it. This study investigated the effects of the time of day at which exposure therapy is delivered and endogenous cortisol levels during exposure on treatment success in pati...
G. Zorzini, P. Ritter, Gianandrea Pallich et al.· Psychoneuroendocrinology· 0 citations
INTRODUCTION
Major depressive disorder (MDD) is highly prevalent and often treatment-resistant. Accelerated intermittent theta burst stimulation (aiTBS) is a promising intervention for treatment-resistant depression (TRD), though outcomes vary. Personality traits have been examined in relation to rTMS outcomes, yet the...
C. Chiarenza, B. Cavendish, D. Mao et al.· Journal of Affective Disorde...· 0 citations
Relapse in alcohol use disorder (AUD) remains a major clinical challenge, influenced by a combination of behavioral and biological factors. While impulsivity and craving have been widely studied, the role of chronotype—a marker of circadian preference—has received limited attention, particularly in Indian populat...
Cognitive behavioral therapy (CBT) with exposure and response prevention is an established treatment for obsessive–compulsive disorder (OCD), yet the electrophysiological indices through which symptom improvement occurs remain incompletely understood. Response inhibition deficits have been implicated in OCD and may rep...
Nonlinear interactions between cortisol indices and daily stressor severity appear to predict 9-year alcohol use disorder and substance use disorder severity, with cortisol area under the curve emerging as the most robust indicator.
Nur Hani Hani Zainal, Natalia Van Doren· Addiction· 0 citations
Electroencephalographic (EEG) biofeedback is a widely used nonpharmaceutical intervention for enhancing human functioning. This pilot study examined whether 24 sessions of alpha-theta (AT) training would reduce stress, as measured by hair cortisol concentration (HCC) and subjective anxiety scales, in 11 adults with gen...
Katya Zlatkova, Cynthia Kerson, Richard Sherman et al.· NeuroRegulation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.